METHOD OF TREATING STAGE IIA HODGKIN'S LYMPHOMA Russian patent published in 2012 - IPC A61N5/10 A61K31/16 A61K31/17 A61K31/475 A61K31/704 A61P35/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely oncology and radiology, and may be used for treating stage IIA Hodgkin's lymphoma. That is ensured by 3-4 therapeutic courses of chemotherapy by the scheme ABVD - adriablastine, bleomycine, vinblastine, dacarbazine. It is followed by chemotherapy by the scheme AVB - adriablastine, vinblastine, dacarbazine. From the 2nd day of the AVD course, the radiation therapy covering initially involved zones is applied at single basic dose 1.2 Gy, daily 2 times a day every 4 hours. If the initial tumour lesion is less than 5 cm, the radiation therapy is applied to total basic dose 30 Gy, while the lesions more than 5 cm requiring dose up to 36 Gy.

EFFECT: method provides reducing total treatment length at least by 2 months, reducing a risk of recurrences, reducing a probability of secondary tumours and late complications of the radiation therapy ensured by the intensified combined chemoradiation treatment.

2 ex